Results 241 to 250 of about 78,184 (307)

Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis. [PDF]

open access: yesPharmaceuticals (Basel)
Hetta HF   +14 more
europepmc   +1 more source

Cardiac safety profiles of first-generation vs second-generation BTK inhibitors: a meta-analysis. [PDF]

open access: yesOncologist
Mushtaq A   +10 more
europepmc   +1 more source

Efficacy and safety of BTK inhibitors in Richter's transformation: a systematic review of clinical evidence. [PDF]

open access: yesFront Oncol
Dirican CD   +7 more
europepmc   +1 more source

Purulent meningitis in X-linked agammaglobulinemia: one case report. [PDF]

open access: yesFront Immunol
Ba A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy